Gruskin Daniel 4
4 · LogicBio Therapeutics, Inc. · Filed Aug 10, 2021
Insider Transaction Report
Form 4
Gruskin Daniel
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-06+4,798→ 4,798 total - Sale
Common Stock
2021-08-09$4.35/sh−1,467$6,381→ 3,331 total - Exercise/Conversion
Restricted Stock Units
2021-08-06−4,798→ 0 total→ Common Stock (4,798 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
- [F2]This sale was made automatically by the Company to cover tax withholding obligations in connection with the vesting and settlement of the RSUs reported in the row above.
- [F3]These RSUs vested on August 6, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan.